1. Home
  2. OSW vs IMNM Comparison

OSW vs IMNM Comparison

Compare OSW & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

HOLD

Current Price

$26.60

Market Cap

2.4B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$25.06

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSW
IMNM
Founded
2017
2006
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
OSW
IMNM
Price
$26.60
$25.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$27.00
$32.80
AVG Volume (30 Days)
821.4K
1.1M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
51.40
EPS
0.44
N/A
Revenue
$961,001,000.00
$6,941,000.00
Revenue This Year
$7.49
N/A
Revenue Next Year
$8.52
$1,127.34
P/E Ratio
$59.91
N/A
Revenue Growth
7.37
N/A
52 Week Low
$19.06
$8.67
52 Week High
$29.25
$27.65

Technical Indicators

Market Signals
Indicator
OSW
IMNM
Relative Strength Index (RSI) N/A 60.18
Support Level N/A $19.28
Resistance Level N/A $25.07
Average True Range (ATR) 0.00 0.99
MACD 0.00 -0.02
Stochastic Oscillator 0.00 85.39

Price Performance

Historical Comparison
OSW
IMNM

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: